A comparative study of acupuncture mono-therapy and acupuncture and moxibustion combination therapy on chemotherapy-induced peripheral neuropathy symptom

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002025

Enrollment

Registered

2016-08-26

Start date

2016-05-30

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Divided into two groups using a block randomization. Each group is treated three times a week for 2 weeks. Then follow up a week later. -controlled group: chemotherapy and acupunctu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. People who aged from 20 to 75 years old, the people has been diagnosed with cancer through biopsy or medical imaging at short-term general hospital. 2. People who scored of ECOG performance 0-2 3. People who experienced peripheral neuropathy after chemotherapy. 4. People who complained for more than a month the CIPN 5. People who graded of CTCAE more than 2 point. 6. People who are available the questioinnaire. 7. People who voluntarily signed a informed consent form. 8. People who are able to follow up during the treatment period. 9. People who are not included in the exclusion criteria.

Exclusion criteria

Exclusion criteria: 1. People who has cardiac disease and uncontrollable hypertension (more than 160/100mmHg) 2. People who are not well controlled diabetic patients (more than 180mg/dl in fasting blood sugar, more than 250mg/dl in random blood sugar except fasting) 3. People who are impossible to treatment due to infection or injury on the treatment area 4. People who has high risk to infection in acupuncture Leukopenia (less than 4,000/?) or neutropenia (less than 1,500/?) 5. People who has known blood coagulopathy or taking heparin/coumadin or thrombocytopenia (less than 50,000/?) 6. People who has peripheral neuropathy due to other disorders. 7. People who are using physical therapy, massotherapy and acupuncture within 2 weeks for improve the CIPN. 8. People who are inappropriate in the study.

Design outcomes

Primary

Measure	Time frame
Decrease score of the Common Terminology criteria for Adverse Events(CTCAE); Decrease score of Visual Analogue Scale(VAS).	—

Secondary

Measure	Time frame
Decrease score of the European Organization for Research and Treatment of Cancer(EORTC) Quality of life questionnaire Chemotherapy-Induced Peripheral Neuropathy 20 (CIPN20).	—

Countries

Korea, Republic of

Contacts

Public ContactLee hye

Daegu Catholic University Medical Center

jhjhjh0669@naver.com

Outcome results